跨美迪克斯医疗 TMDX
$88.24 +$19.26 (+27.92%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $87.79 -0.51%
开盘$79.12
昨收$68.98
当日区间$76.50 – $88.44
成交量3.95M
市值$3.06B
市盈率（TTM）24.0
股息率–
TMDX 相关新闻
匹配 TransMedics 或代码 TMDX 的头条新闻，按最新排序。
- Needham Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $106
- Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $90 负面
- Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Raises Target Price to $100 正面
- GUIDANCE: (TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M - $757M, Vs. FactSet Est of $743.1M
- A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $95 to $106
- A Quick Look at Today's Ratings for TransMedics(TMDX.US), With a Forecast Between $95 to $122
- Needham Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $106 负面
- TransMedics (TMDX): Buy Rating Backed by Accelerating U.S. Organ Transplant Volumes and Expanding OCS Utilization
- Oppenheimer Maintains TransMedics(TMDX.US) With Hold Rating
- CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $95
- Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $120 负面
- Evercore Maintains TransMedics(TMDX.US) With Buy Rating, Cuts Target Price to $90 负面
- Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $120
- CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $124
- Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)
暂无评论——快来第一个聊聊 TMDX。
登录后参与讨论。